X

pharmaceuticals

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of…

Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript

Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck -- Head of Investor Relations…

BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results

Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to…

Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook

Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom…

Pfizer (PFE) stock research summary | Q3 2021

Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s…

ACB Earnings: Aurora Cannabis Q1 2022 revenue down 11%

Aurora Cannabis, Inc. (NYSE: ACB) on Tuesday reported a loss for the first quarter of 2022 when its revenues declined…

IPO news: A few points to keep in mind as Vaxxinity makes its market debut this week

The healthcare industry continues to thrive and many companies in this sector have lined up to go public in recent…

Pfizer (PFE): Comirnaty and a strong pipeline provides long-term growth opportunity

Shares of Pfizer Inc. (NYSE: PFE) gained 4% on Tuesday after the company delivered strong results for the third quarter…

Key highlights from Pfizer (PFE) Q3 2021 earnings results

Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today. Revenues more than doubled year-over-year to $24 billion. Reported…

Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues

Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The…

Merck beats market estimates in Q3: Infographic

Merck (NYSE: MRK) reported third-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q3…

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?

The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective…

Infographic: How Tilray (TLRY) performed in Q1 2022

Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43%…

Infographic: Highlights of Aurora Cannabis (ACB) Q4 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary

It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025.…

Medicure Inc (MPH) Q2 2021 Earnings Call Transcript

Medicure Inc (CVE:MPH) Q2 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Albert D. Friesen -- Chief Executive Officer…

Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript

Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive…

IPO News: Should you invest in RenovoRx’s upcoming IPO?

As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the…

Should you buy Agilent Technologies (A) stock ahead of next week’s earnings?

The impact of the COVID crisis on Agilent Technologies, Inc. (NYSE: A), a leading provider of medical diagnostic devices, has…

IPO News: What to look for when Eliem Therapeutics goes public?

Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to…